CV Sciences, Inc.
CVSI
$0.03
$0.006.15%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.79M | 14.37M | 14.98M | 15.31M | 15.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.79M | 14.37M | 14.98M | 15.31M | 15.71M |
| Cost of Revenue | 7.04M | 7.61M | 8.02M | 8.34M | 8.54M |
| Gross Profit | 6.75M | 6.76M | 6.96M | 6.97M | 7.17M |
| SG&A Expenses | 7.62M | 7.95M | 8.33M | 8.36M | 8.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -522.00K | -522.00K | -522.00K | -522.00K | -- |
| Total Operating Expenses | 14.26M | 15.16M | 15.96M | 16.28M | 17.31M |
| Operating Income | -470.00K | -798.00K | -984.00K | -972.00K | -1.60M |
| Income Before Tax | -949.00K | -1.49M | -1.56M | -1.88M | -2.40M |
| Income Tax Expenses | 9.00K | -7.00K | -7.00K | -7.00K | -8.00K |
| Earnings from Continuing Operations | -0.96 | -1.48 | -1.55 | -1.88 | -2.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -958.00K | -1.48M | -1.55M | -1.88M | -2.39M |
| EBIT | -470.00K | -798.00K | -984.00K | -972.00K | -1.60M |
| EBITDA | -278.00K | -513.00K | -649.00K | -619.00K | -1.27M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 737.06M | 737.12M | 735.12M | 723.27M | 702.08M |
| Average Diluted Shares Outstanding | 737.06M | 737.12M | 735.12M | 723.27M | 702.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |